PXC2


Biophysical analysis is now playing a significant role in the research and early development for a new generation of complex protein therapeutics.  The combination of improved understandings of the structure and function of proteins with advanced, higher resolution analytical methods helps researchers identify and fine-tune candidate molecules before advancing them into development.  As protein engineers and analytical scientists increase their reliance on biophysical analysis, they are driving a move to instruments with higher throughput and resolution – and working to quantify analytical results previously used only for qualitative assessments.  The Biophysical Analysis meeting at PEGS will bring together an international audience of protein scientists and analytical specialists to explore the latest technologies and techniques used for problem solving in this dynamic field.

Topics may include, but are not limited to:

  • Analysis of higher order structures for fingerprinting and comparability analysis
  • Automation and computational tools in biophysical analysis
  • Correlation of experimental and simulation results; constrained simulation space
  • Emerging biophysical analytical methods and approaches
  • Identifying problematic antibody sequences early in discovery
  • Imaging and microscopy applications in biophysical analysis
  • Measuring and understanding protein dynamics
  • Next generation assays; miniaturization and improved resolution
  • Particle analysis: update and next steps for the industry
  • Protein engineering and design for improved biophysical properties

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract.  Remember to specify the conference that you are interested in and please provide your full contact information.

Deadline for submission is Friday, September 25, 2015

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conferene program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute
Phone: 207-869-9199
E-mail: ksimmons@healthtech.com

Jason Gerardi
(Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5452
E: jgerardi@healthtech.com

Carol Dinerstein
(Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: 781.972.5471
E: dinerstein@healthtech.com